Page last updated: 2024-09-03

gefitinib and Adenocarcinoma, Scirrhous

gefitinib has been researched along with Adenocarcinoma, Scirrhous in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	1 (100.00)	29.6817
2010's	0 (0.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Date, M; Fujise, K; Matsumoto, K; Nakamura, T; Namiki, T; Namiki, Y; Satoi, J; Tada, N; Yanagihara, K; Yashiro, M; Yoshida, H	1

Other Studies

1 other study(ies) available for gefitinib and Adenocarcinoma, Scirrhous

Article	Year
Preclinical study of a "tailor-made" combination of NK4-expressing gene therapy and gefitinib (ZD1839, Iressa) for disseminated peritoneal scirrhous gastric cancer. International journal of cancer, 2006, Mar-15, Volume: 118, Issue:6 Topics: Adenocarcinoma, Scirrhous; Administration, Oral; Adult; Animals; Antineoplastic Agents; Cell Line; Cell Line, Tumor; Cell Proliferation; Cytokines; Dose-Response Relationship, Drug; ErbB Receptors; Gefitinib; Genetic Therapy; Hepatocyte Growth Factor; Humans; Male; Mice; Mice, Inbred BALB C; Mice, Nude; Peritoneum; Quinazolines; Stomach Neoplasms; Survival Analysis; Treatment Outcome; Tumor Cells, Cultured; Xenograft Model Antitumor Assays	2006

Article

Year

Preclinical study of a "tailor-made" combination of NK4-expressing gene therapy and gefitinib (ZD1839, Iressa) for disseminated peritoneal scirrhous gastric cancer.

International journal of cancer, 2006, Mar-15, Volume: 118, Issue:6

Topics: Adenocarcinoma, Scirrhous; Administration, Oral; Adult; Animals; Antineoplastic Agents; Cell Line; Cell Line, Tumor; Cell Proliferation; Cytokines; Dose-Response Relationship, Drug; ErbB Receptors; Gefitinib; Genetic Therapy; Hepatocyte Growth Factor; Humans; Male; Mice; Mice, Inbred BALB C; Mice, Nude; Peritoneum; Quinazolines; Stomach Neoplasms; Survival Analysis; Treatment Outcome; Tumor Cells, Cultured; Xenograft Model Antitumor Assays

2006